<DOC>
	<DOCNO>NCT02765646</DOCNO>
	<brief_summary>The objective study demonstrate clinical performance Tryton Side Branch Stent use conjunction commercially available Drug Eluting Stent ( DES ) treat de novo bifurcate lesion involve Left Main ( LM ) Circumflex Coronary Artery ( LCX ) .</brief_summary>
	<brief_title>eTryton Left Main Registry Tryton Side Branch Stent® Tmt Denovo CAD LM CFX Arteries</brief_title>
	<detailed_description>The registry study involve collection demographic clinical data , include in-hospital follow-up data determine primary composite endpoint MACE ( Major Adverse Cardiac Events ) 9 month secondary endpoint . Secondary endpoint define successful deployment Tryton stent main vessel DES within target lesion , angiographic success &lt; 30 % residual stenosis LM LAD/LCX visual estimate TIMI 3 flow post procedure , freedom in-hospital MACE .</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>1 . Patient ≥18 year old ; 2 . Patient eligible percutaneous coronary intervention ( PCI ) ; 3 . Patient acceptable candidate CABG ; 4 . Clinical evidence ischemic heart disease / positive functional registry . Documented stable angina pectoris ( Canadian cardiovascular society classification ( CCS ) 1 , 2 , 3 4 ) , unstable angina pectoris ( Braunwald Class IBC , IIBC , IIIBC ) , document silent ischemia ; 5 . Single high grade de novo bifurcation lesion ≥50 % &lt; 100 % stenosis distal part leave main , require stent placement across LCx Ostium , TIMI flow &gt; 2 visual estimation ; 6 . The target lesion length must able cover single main vessel stent ≥ 5.0mm ≤ 32 mm main vessel ≤ 32 mm side branch ( visual estimate ) cover one Tryton stent one DES side branch ; 7 . The reference vessel diameter main branch must ≥ 2.5mm ≤ 4.0 mm ( visual estimate ) reference vessel diameter side branch must ≥ 2.25mm ≤ 3.5 mm ( visual estimate ) ; 8 . If require local regulation , patient informed nature registry , agree provision provide write informed consent , approve appropriate Medical Ethics Committee ( MEC ) respective clinical site ; 9 . The patient willing comply followup evaluation . 1 . Female childbearing potential ; 2 . Documented leave ventricular ejection fraction ( LVEF ) ≤30 % ; 3 . Evidence acute myocardial infarction within 48 hour intend treatment ; 4 . Known allergy follow : Acetylsalicylic acid ( ASA ) ( Aspirin® ) , Clopidogrel bisulfate ( Plavix® . ) Ticlopidine ( Ticlid® . ) , Heparin , contrast agent ( adequately premedicated ) ; 5 . Acute chronic renal dysfunction ( serum creatinine &gt; 2.0 mg/dl &gt; 150μmol/L ) ; 6 . Target vessel angiographic evidence thrombus ; 7 . Previous interventional procedure ( less 1 year ) anywhere within leave main artery include bifurcation LAD and/or LCX ; 8 . Anticipated use rotational atherectomy 9 . Significant ( &gt; 50 % ) stenosis proximal distal target lesion might require revascularization impede run offCONFIDENTIAL Page 7 18 August 11 , 2015 version 5 treated index procedure ; 10 . Heavily calcified lesion and/or calcify lesion successfully predilated ; 11 . Prior stent Left Main ; 12 . Prior stent within 5mm distal target lesion ; 13 . Total occlude dominant RCA ; 14 . Trifurcation lesion Ramus Intermedius diameter &gt; 2.0 mm ; Diagonal Branch diameter &gt; 2.0 mm within 5 mm LAD origin ; Obtuse Marginal &gt; 2.0 mm diameter within 5 mm LCx origin ; 15 . Patient currently participate investigational drug device registry complete primary endpoint clinically interfere current registry endpoint . 16 . Stroke transient ischemic attack within prior 6 month ; 17 . In Investigator 's opinion patient comorbid condition ( ) could limit patient 's ability participate registry , compliance followup requirement impact scientific integrity registry ; 18 . Recipient heart transplant ; 19 . Life expectancy less 1 year ; 20 . Braunwald Class IA , IIA IIA angina pectoris ; 21 . Patients severe congestive heart failure ; 22 . Patients severe heart failure NYHA IV ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>